ArticleHemaSphere2025

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

David Rombaut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.